(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

DERIVADOS DE PIRROLOPIRAZINA COMO INIBIDORES DE ALFA V INTEGRINA

ArquivadaInvention PatentPCT · US2018059157

Application data

Number

112020008893

Type

Invention Patent

Filing

11/05/2018

Publication

10/13/2020

PCT

US2018059157

Progress at the INPI

  1. Filing11/05/18
  2. Publication10/13/20
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 11/05/2018 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 05/10/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

BRISTOL-MYERS SQUIBB COMPANY

US

See this company's full portfolio

Inventors

G. Z. (pessoa física)

US

J. M. (pessoa física)

US

Technical data

Priority claims

US

62/582,693 · 11/07/2017

Abstract

A invenção refere-se aos compostos de Fórmula I: Ique inibem integrinas contendo alfaV, e inclui composições farmacêuticas que compreendem estes compostos e métodos de tratamento de uma doença, distúrbio, ou condição associada com a desregulação de integrinas contendo alfaV, tais como fibrose patológica, rejeição a transplante, câncer, osteoporose, e distúrbios inflamatórios.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

05/10/2022

RPI 2679

Arquivamento - Art. 33 da LPI

#11.1

02/22/2022

RPI 2668

Adição na publicação

#15.35

11/23/2021

RPI 2655

Notificação de entrada na fase nacional - PCT

#1.3

10/13/2020

RPI 2597

Alteração de dados cadastrais

#1.1

09/29/2020

RPI 2595

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.